BRIEF published on 04/17/2026 at 09:05, 22 days 7 hours ago Aiforia Technologies décroche un partenariat exclusif en IA en France Diagnostic Par IA Technologies Aiforia Projet PROSTIA Partenariat AP-HP Soins De Santé Français
BRIEF published on 04/17/2026 at 09:05, 22 days 7 hours ago Aiforia Technologies Secures Exclusive AI Partnership in France AI Diagnostics Aiforia Technologies PROSTIA Project AP-HP Partnership French Healthcare
PRESS RELEASE published on 04/17/2026 at 09:00, 22 days 7 hours ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj selected as sole AI partner for PROSTIA project by Assistance Publique-Hôpitaux de Paris, expanding cancer diagnostics in France. Landmark deployment validates Aiforia's market leadership Cancer Diagnostics France AI Partner Aiforia Technologies Oyj PROSTIA Project
BRIEF published on 03/11/2026 at 09:05, 1 month 29 days ago Aiforia Technologies Oyj enregistre une forte croissance clinique Marché Européen Amélioration De La Rentabilité Expansion De La Clientèle Position De Trésorerie Croissance Clinique
BRIEF published on 03/11/2026 at 09:05, 1 month 29 days ago Aiforia Technologies Oyj Sees Clinical Growth Surge European Market Cash Position Profitability Improvement Client Expansion Clinical Growth
PRESS RELEASE published on 03/11/2026 at 09:00, 1 month 29 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 2 months ago Aiforia Technologies Oyj prête pour la croissance dans le segment clinique Partenariats Stratégiques Part De Marché Amélioration De L'EBITDA Expansion Des Revenus Croissance Clinique
BRIEF published on 03/09/2026 at 09:05, 2 months ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 2 months ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 02/27/2026 at 09:05, 2 months 10 days ago Aiforia Technologies Oyj anticipe une forte croissance de ses revenus cliniques Croissance Financière Rentabilité Partenariats Stratégiques Technologie IA Revenus Cliniques
Published on 05/09/2026 at 01:30, 15 hours 3 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 16 hours 33 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 19 hours 54 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 21 hours 20 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 21 hours 30 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
